Commercial Information Circulars
24-hour hotline : 23 922 922
e-mail address : enquiry@tid.gov.hk
Ref. : EIC 631/2/5/1
11 October 2022
Dear Sirs,
Commercial Information Circular No. 792/2022
The Mainland of China : Public Consultation on "Opinions of Reforming and Improving the Administration of Examination and Approval of Radioactive Drugs (Consultation Draft)"
The National Medical Products Administration is seeking comments from the public on the "Opinions of Reforming and Improving the Administration of Examination and Approval of Radioactive Drugs (Consultation Draft)". Interested parties can submit their comments before 31 October 2022. Please refer to the Appendix (pdf format) for the notice (available in Chinese only).
ENQUIRIES
2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.
Yours faithfully,
(Miss Bonny CHAO)
for Director-General of Trade and Industry
Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.